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CD8+ T cells undergo major metabolic changes upon
activation, but howmetabolism influences the estab-
lishment of long-lived memory T cells after infection
remains a key question. We have shown here that
CD8+ memory T cells, but not CD8+ T effector (Teff)
cells, possessed substantial mitochondrial spare
respiratory capacity (SRC). SRC is the extra capacity
available in cells to produce energy in response to
increased stress or work and as such is associated
with cellular survival. We found that interleukin-15
(IL-15), a cytokine critical for CD8+ memory T cells,
regulated SRC and oxidative metabolism by pro-
moting mitochondrial biogenesis and expression of
carnitine palmitoyl transferase (CPT1a), a metabolic
enzyme that controls the rate-limiting step to mito-
chondrial fatty acid oxidation (FAO). These results
show how cytokines control the bioenergetic
stability of memory T cells after infection by regu-
lating mitochondrial metabolism.INTRODUCTION
CD8+ T cells play a crucial role in immunity to infection and
cancer. In response to antigen (Ag) and costimulation, CD8+
T cells undergo a developmental program characterized by
distinct phases encompassing first the expansion, and then
contraction, of Ag-specific effector T (Teff) cell populations,
followed by the persistence of long-lived memory T cells that
mediate immunity to reinfection (Harty and Badovinac, 2008).
Although this predictable pattern of the response is well charac-
terized, the mechanisms underlying the generation and mainte-
nance of CD8+memory T cells, and in particular howmetabolism
influences this process, remain unclear.
Upon activation, T cells undergo a metabolic switch to glycol-
ysis, which is required to support their growth, proliferation, and
effector functions (Krauss et al., 2001; Rathmell et al., 2000;
Roos and Loos, 1973). Conventional views suggest that prolifer-
ating T cells ferment glucose to make ATP, even though there is
sufficient oxygen present to support oxidative phosphorylation68 Immunity 36, 68–78, January 27, 2012 ª2012 Elsevier Inc.(OXPHOS) (Brand and Hermfisse, 1997; Greiner et al., 1994;
Wang et al., 1976), a phenomenon known as the Warburg effect
(Warburg, 1956). Signals from IL-2 and costimulatory CD28
support the activation and expansion of T cells by promoting
this metabolic phenotype (Frauwirth et al., 2002; Wieman et al.,
2007). In contrast to the glycolytic metabolism of T cells prolifer-
ating in response to Ag, it is thought that quiescent T cells (e.g.,
naive and memory T cells), like most cells in normal tissues, use
OXPHOS to meet energy demands (Krauss et al., 2001) by inter-
changeably breaking down glucose, amino acids, and fats to fuel
the tricarboxylic acid (TCA) cycle and ATP production (Fox et al.,
2005; Jones and Thompson, 2007). Implicit in this divergence in
metabolism between activated and quiescent T cells is that the
conversion, or switching, between differing metabolic states
is required to effectively generate a given T cell fate. This has
clearly been shown to be the case for the switch to glycolysis
that accompanies naive T cell activation (Fox et al., 2005; Jones
and Thompson, 2007). Although it is known that growth factor
cytokines support the survival of resting T cells, how cells
attain a quiescent state, and the accompanying metabolic
transformation to OXPHOS that would presumably occur during
the development of stable CD8+memory T cells after infection, is
incompletely understood.
Previously we demonstrated that pharmacological modulation
of fatty acid oxidation (FAO) enhanced CD8+ memory T cell
development after vaccination (Pearce et al., 2009). However,
understanding the metabolic features of CD8+ memory T cells,
and the mechanistic insight into why FAO is critical for CD8+
memory T cells, is still lacking. By using extracellular flux anal-
ysis, we investigated the metabolism of T cells after infection in
real time and discovered a striking mitochondrial marker that is
unique to CD8+ memory T cells. We show here that CD8+
memory T cells, unlike CD8+ Teff cells or resting naive CD8+
T cells, maintained substantial spare respiratory capacity
(SRC) in their mitochondria. SRC is the extra mitochondrial
capacity available in a cell to produce energy under conditions
of increased work or stress and is thought to be important for
long-term cellular survival and function (Choi et al., 2009; Ferrick
et al., 2008; Nicholls, 2009; Nicholls et al., 2010; Yadava and
Nicholls, 2007). We show here that SRC in CD8+ memory
T cells was dependent upon the ability of the cells to oxidize
fats in their mitochondria. We demonstrate that IL-15, a cytokine
critical for CD8+ memory T cells (Kennedy et al., 2000; Ku
et al., 2000; Mitchell et al., 2010; Sandau et al., 2010;
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Figure 1. CD8+ Memory T Cells Have
Substantial Mitochondrial Spare Respira-
tory Capacity
Spleens and lymph nodes were harvested from
naive and LmOVA-infected mice, and Tn, Teff, and
memory T cells were isolated.
(A) O2 consumption rates (OCR) were measured in
real time under basal conditions and in response
to indicated mitochondrial inhibitors; p < 0.0001
after FCCP injection. Data are representative of
four independent experiments.
(B) Extracellular acidification rates (ECAR) were
measured under basal conditions; *p < 0.01 for
Teff versus Tn cells, and *p < 0.01 for Teff versus
memory T cells. Data are representative of two
independent experiments.
(C–F) OT-I cells were activatedwith OVA peptide in
the presence of IL-2 for 3 days and subsequently
cultured in either IL-2 or IL-15 to generate IL-2 Teff
and IL-15 memory T cells, respectively. Basal
extracellular acidification rate (ECAR) (D), basal
OCR/ECAR ratio (E), and OCR under basal con-
ditions and in response to indicated mitochondrial
inhibitors (F) in IL-2 Teff and IL-15 memory T cells
are shown; *p < 0.0001 (D), *p < 0.0001 (E),
*p < 0.0001 (F after FCCP). Data are representative
of at least three independent experiments.
Dataareshownasmean±SEM.SeealsoFigureS1.
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Mitochondrial Capacity and CD8+ T Cell MemorySchluns et al., 2002; Surh and Sprent, 2008; Tan et al., 2002;
Zhang et al., 1998), enhanced SRC by promoting mitochondrial
biogenesis and the expression of carnitine palmitoyl transferase
1a (CPT1a), a mitochondrial protein that has been shown to play
an important role in the utilization of fatty acids as an alternative
energy source (Deberardinis et al., 2006; Ramsay and Zammit,
2004; Zaugg et al., 2011). Our genetic experiments show that
CPT1a, and thus FAO, regulated SRC and CD8+ memory T cell
development. Our data indicate that maintaining mitochondrial
function and SRC in CD8+ T cells is key to stable CD8+ memory
T cell formation after infection.
RESULTS
CD8+ Memory T Cells Have Substantial Mitochondrial
Spare Respiratory Capacity
To establish how cellular metabolism is regulated during an
immune response, we measured the bioenergetic profiles of
CD8+ naive T (Tn) cells, and Teff and memory T CD8+ cells
from wild-type (WT) mice infected with Listeria monocytogenes,
in a basal state and after the addition of oligomycin (to block ATP
synthesis), FCCP (to uncouple ATP synthesis from the electron
transport chain, ETC), and rotenone and antimycin A (to block
complex I and III of the ETC, respectively) (Figure S1A available
online; Gerencser et al., 2009; Nicholls et al., 2010). We found
that the O2 consumption rate (OCR), an indicator of OXPHOS
(Figure S1B), was slightly higher in memory T cells in the basalImmunity 36, 68–7state when compared to Teff and Tn cells
(Figure 1A), whereas the basal extracel-
lular acidification rate (ECAR), a conse-
quence of lactic acid production (whichis a marker of glycolysis), was greatest in Teff cells (Figure 1B).
Strikingly, however,memory T cells demonstrated a substantially
larger mitochondrial SRC when compared to Teff and Tn cells,
as indicated by the difference between the maximal OCR (after
FCCP injection) and basal OCR (Figures 1A and S1B).
CD8+ memory T cells are characterized by their ability to
persist for long periods of time and to respond vigorously to
antigen re-encounter (Prlic et al., 2007). Because SRC is thought
to be important for cellular survival and function (Choi et al., 2009;
Ferrick et al., 2008; Nicholls, 2009; Nicholls et al., 2010; Yadava
and Nicholls, 2007), we explored the role of SRC in CD8+ T cells.
We investigated whether the cytokines IL-2 and IL-15, which are
critical for the development and maintenance of CD8+ Teff cells
and memory T cells, respectively (Kennedy et al., 2000; Mitchell
et al., 2010; Sandau et al., 2010; Schluns et al., 2002; Surh and
Sprent, 2008; Tan et al., 2002; Zhang et al., 1998), influence
SRC. We isolated CD8+ T cells from major histocompatibility
(MHC) class I-restricted OT-I transgenic mice and measured
their bioenergetic profiles after stimulation with OVA peptide
and IL-2 for 3 days, followed by 4 days of culture in either IL-2
or IL-15 (Figure 1C; Carrio et al., 2004). These in vitro culture
conditions approximate the program of Teff cell and memory
T cell development after the response to an infection in vivo.
Upon infection, antigen and IL-2 promote CD8+ Teff cell activa-
tion and proliferation, followed by the contraction of these cell
populations as infection is cleared and antigen and growth
factors such as IL-2 decline. During this time, presumably,8, January 27, 2012 ª2012 Elsevier Inc. 69
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Figure 2. IL-15 Signals Promote CD8+ T Cell Survival
OT-I cells were activated with OVA peptide in the presence of IL-2 for 3 days
and subsequently cultured in either IL-2 or IL-15.
(A) IL-2 Teff and IL-15 memory T cells were restimulated with anti-CD3 and
anti-CD28 for 5 hr and the amounts of restimulation-induced ATP are shown
relative to nonrestimulated cells (dashed line); *p = 0.03. Data are shown as
mean ± SEM and are representative of two independent experiments.
(B and C) IL-2 cultured Teff cells were withdrawn from IL-2 for 6–8 hr, and (B)
relative Bcl-2 mRNA expression and (C) percentage live cells (based on 7-AAD
analysis) are shown. Data are shown as the mean ± SEM (figure generated
from two independent experiments) (B) or as a representative experiment of
three independent experiments (C).
(D) IL-2 Teff and IL-15 memory T cells were adoptively transferred into con-
genic recipients (n = 5 per group), and organs were harvested 2 days later;
dot plots show percentages (top) or total numbers (bottom) of donor cells.
Data are shown as mean ± SEM. Data are representative of two independent
experiments. *p = 0.004 (top left), *p < 0.0001 (top right), *p < 0.005 (bottom
left), and *p < 0.0001 (bottom right).
See also Figure S2.
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70 Immunity 36, 68–78, January 27, 2012 ª2012 Elsevier Inc.exposure to cytokines such as IL-15 promotes the development
and maintenance of CD8+ memory T cells (Sandau et al., 2010;
Schluns et al., 2002; Zhang et al., 1998). Culture with IL-2 and
IL-15 induced Teff-like cells (IL-2 Teff cells) and memory-like
T cells (IL-15memory T cells), respectively, which displayed acti-
vation marker phenotypes similar to Teff and memory T cells
generated after infection (Figure S1C;Carrio et al., 2004). Consis-
tent with the idea that proliferating T cells use glycolysis for
energy (Frauwirth et al., 2002; Jones and Thompson, 2007), we
found that IL-2 Teff cells displayed high basal ECAR (Figure 1D)
when compared to IL-15 memory T cells. In contrast, although
IL-15 memory T cells were less metabolically active in a basal
state, as shown by lower basal ECAR (Figure 1D) and OCR (Fig-
ure S1D) when compared to IL-2 Teff cells, they possessed
a higher OCR/ECAR ratio (Figure 1E). This would indicate that
IL-15 memory T cells preferentially use OXPHOS rather than
glycolysis. We found that IL-15 promoted SRC in activated
CD8+ T cells, whereas CD8+ T cells cultured in the presence of
IL-2 lacked this energy reserve (Figure 1F). In addition, to rule
out effects from substrate limitations during the assay, we per-
formed the assay in the absence or presence of 10% serum
and observed similar results (data not shown). Consistent with
the idea that SRC is an intrinsic feature of CD8+ memory
T cells, we found that culture with IL-7, which also promotes
the development of CD8+ memory T-like cells in vitro (Carrio
et al., 2004) and is important for the CD8+ memory T cell homeo-
stasis in vivo (Tan et al., 2002), enhanced SRC (data not shown).
To determine how SRC correlates with the ability to produce
energy in response to increased work, we restimulated IL-2
Teff and IL-15 memory T cells with anti-CD3 and anti-CD28
and found that IL-15 memory T cells have an increased amount
of ATP after restimulation when compared to IL-2 Teff cells
(Figure 2A). Moreover, upon restimulation, IL-2 Teff cells had
decreased mitochondrial membrane potential (Jmito) and
enhanced superoxide production (Figures S2A and S2B), two
parameters that indicate poor mitochondrial health (Grayson
et al., 2003; Lambert and Brand, 2009; Mookerjee et al., 2010).
Meanwhile IL-15 memory T cells showed increased Jmito and
lower superoxide concentration. Consistent with this, IL-15
memory T cells survived better (Figure S2C) after restimulation
when compared to IL-2 Teff cells. Because upon restimulation
memory T cells should convert to a Teff cell phenotype, we
tested whether restimulating IL-15 memory T cells resulted in
a metabolic switch from OXPHOS to glycolysis. Indeed, upon
stimulation with PMA and ionomycin, IL-15 memory T cells
rapidly increased their ECAR (Figure S2D) and decreased their
OCR/ECAR ratio (Figure S2E), and a longer stimulation with
anti-CD3 and anti-CD28 also resulted in a lower OCR/ECAR
ratio (Figure S2F) in those cells. Because all cells in these
cultures were first activated with OVA peptide in the presence
of IL-2, we wanted to establish that signals from IL-15, rather
than simply thewithdrawal of IL-2, regulated CD8+ T cell survival.
Indeed, we found that Bcl-2 expression, which correlates with
CD8+ T cell survival (Grayson et al., 2000), was highest in IL-15
memory T cells (Figure 2B), and that CD8+ T cells after IL-2 with-
drawal were not long-livedwithout signals from IL-15 (Figure 2C).
To explore whether IL-15 memory T cells survived better in vivo,
we adoptively transferred IL-2 Teff cells or IL-15 memory T cells
into congenic mice and after 2 days we found significantly more
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Figure 3. IL-15 Induces Mitochondrial Biogenesis
in CD8+ T Cells
IL-2 Teff and IL-15 memory T cells were analyzed.
(A) Confocal images show cells stained with Mitotracker
(green), Hoechst (blue), and anti-CD8 (white); scale bars
represent 5 mm.
(B–D) mtDNA/nDNA ratio (figure generated from two
independent experiments), *p = 0.01 (B); protein immu-
noblot for complex I expression (C); and relative mito-
chondrial transcription factor A (TFAM) mRNA expression
(figure generated from five independent experiments) in
IL-2 Teff and IL-15 memory T cells; *p = 0.008 (D).
(E and F) Relative total amount of NAD(H), NAD/NADH ratio
(E), and NADH consumed by the ETC (measured as NADH
built up after ETC blockade) (F) in IL-2 Teff and IL-15
memory T cells (figures generated from three independent
experiments); *p = 0.03.
Data are shown as mean ± SEM. Data in (A) and (C) are
representative of at least three independent experiments.
See also Figure S3.
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Mitochondrial Capacity and CD8+ T Cell Memorydonor IL-15 memory T than donor IL-2 Teff cells in spleen and
lymph nodes (Figure 2D), which is consistent with data showing
that IL-15 is critical for CD8+ T cell persistence (Kennedy et al.,
2000; Sandau et al., 2010; Schluns et al., 2002). Together the
data suggest that enhanced SRC enables memory T cells to
survive as functional long-lived cells and that this process is
modulated by IL-15.
IL-15 Induces Mitochondrial Biogenesis in CD8+ T Cells
Because SRC is a measure of how efficiently the ETC can move
protons from the mitochondrial matrix into the intermembrane
space in the presence of the uncoupler FCCP as compared to
the basal state (Figure S1A; Mookerjee et al., 2010; Nicholls
et al., 2010), we reasoned that the enhanced SRC evident in
IL-15 memory T cells might be explained by an increase in mito-
chondrial mass. IL-2 Teff cells are larger than IL-15 memory
T cells (Carrio et al., 2004; Cornish et al., 2006; Rathmell et al.,
2000), and we found that their larger cytoplasm had a dispersed
mitochondrial distribution (Figure 3A). In contrast, IL-15 memory
T cells had a smaller cytoplasmic space with tightly packed
mitochondria, indicating a difference in the ratio between mito-
chondrial mass and total cell mass between Teff and memory
T cells (Figures 3A and S3). We next tested whether IL-15
induced mitochondrial biogenesis in CD8+ T cells by quantifying
the ratio of mitochondrial DNA to nuclear DNA (mtDNA/nDNA)
and found that this ratio was higher in IL-15 memory T cells
than in IL-2 Teff cells (Figure 3B). We also found that IL-15
memory T cells expressed more ETC protein complex I (Fig-Immunity 36ure 3C), which has previously been reported
to be important for memory T cell function
(Yi et al., 2006). Moreover, IL-15 memory
T cells had greater expression of mitochondrial
transcription factor A (TFAM) mRNA (Figure 3D).
Together, these data demonstrate the en-
hanced mitochondrial content of IL-15 memory
T cells. NADH is generated by the TCA cycle
and donates electrons to complex I as part of
OXPHOS (Figure S1A; Saraste, 1999). To testwhether enhanced NADH availability further contributes to the
greater SRC in IL-15 memory T cells, we measured the amount
of NAD(H) (total NAD+ and NADH) and found that IL-15 memory
T cells actually had less NADH, as demonstrated by a lower
amount of total NAD(H) and a higher NAD/NADH ratio, than
IL-2 Teff cells (Figure 3E). Importantly, when NADH consumption
by the ETC was blocked with rotenone and antimycin A, IL-15
memory T cells accumulated more NADH than did IL-2 Teff cells
(Figure 3F). This would suggest that IL-15 memory T cells prefer-
entially use OXPHOS to generate energy, correlating with our
results, showing that IL-15 memory T cells have higher OCR/
ECAR ratios (Figure 1E). Together these data show that IL-15
induces mitochondrial biogenesis in CD8+ T cells and that
greater mitochondrial mass, rather than greater NADH avail-
ability, contributes to enhanced SRC in these IL-15 memory
T cells.
To confirm that bona fide CD8+ memory T cells isolated after
L. monocytogenes infection had enhanced mitochondrial
content, we quantified the ratio of mtDNA/nDNA and found
that this ratio was higher in CD8+ memory T cells than in CD8+
Teff cells (Figure 4A). Notably, CD8+ Tn cells had fewer mito-
chondria than memory T cells, indicating that enhanced mito-
chondrial mass is not a characteristic of resting T cells in
general, but is unique to memory T cells. This correlates with
our finding that only memory T cells, and not Tn and Teff cells,
have considerable SRC. In addition, bona fide CD8+ memory
T cells had a denser mitochondrial distribution, whereas
mitochondria in CD8+ Teff cells were generally more disperse, 68–78, January 27, 2012 ª2012 Elsevier Inc. 71
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Figure 4. CD8+ Memory T Cells Have Greater Mito-
chondrial Mass than CD8+ Teff Cells
Spleens and lymph nodes were harvested from naive and
LmOVA-infected mice, and Tn, Teff, and memory T cells
were isolated.
(A) mtDNA/nDNA ratio (data are shown as mean ± SEM,
figure generated from two independent experiments)
*p < 0.01 for Teff versus memory T cells, and *p < 0.05 for
Tn versus memory T cells.
(B) Confocal images show Tn, Teff, and memory T cells
stained with Mitotracker (green) and Hoechst (blue); scale
bars represent 5 mm.
(C) Relative mitochondrial transcription factor A (TFAM)
mRNA expression (data are shown as mean ± SEM, figure
generated from two independent experiments), *p = 0.01.
(D) Protein immunoblot for complex I expression (bars
depict quantification of densitometry from three blots),
*p = 0.008. Data are representative of two independent
experiments.
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Mitochondrial Capacity and CD8+ T Cell Memory(Figure 4B). We also found that CD8+ memory T cells had
significantly higher TFAM mRNA (Figure 4C) and complex I
protein expression when compared to CD8+ Teff cells (Fig-
ure 4D). Together, our data indicate that CD8+ memory T cells
have greater mitochondrial mass and this underlies their
enhanced SRC.
Spare Respiratory Capacity in CD8+ T Cells Is
Dependent on Mitochondrial Fatty Acid Oxidation
Our previous studies showed that pharmacologically modu-
lating FAO after infection could promote the generation of
CD8+ memory T cells (Pearce et al., 2009). Because IL-15 is
known to promote memory T cell development (Sandau et al.,
2010; Schluns et al., 2002; Zhang et al., 1998), and we have
shown here that IL-15 supports SRC in CD8+ T cells, we sought
to determine whether IL-15-enhanced SRC is associated with
mitochondrial FAO. The rate-limiting step to FAO is the transfer
of fatty acids from the cytosol into mitochondria by carnitine
palmitoyltransferase 1 (CPT1) (Deberardinis et al., 2006; Ram-
say and Zammit, 2004). We measured CPT1a mRNA in IL-2
Teff and IL-15 memory T cells and found that IL-15 memory
T cells expressed more CPT1a mRNA (Figure 5A). This indi-
cates that IL-15 promotes the use of fatty acids for energy
and correlates with our finding that IL-15 induces mitochondrial
biogenesis.72 Immunity 36, 68–78, January 27, 2012 ª2012 Elsevier Inc.To determine whether the enhanced SRC in
IL-15 memory T cells depends on FAO, we
exposed IL-15 memory T cells to the CPT1
inhibitor etomoxir, which blocks mitochondrial
FAO (Deberardinis et al., 2006; Lopaschuk
et al., 1988). Treatment with etomoxir, either
before or after FCCP injection, impaired SRC
in IL-15 memory T cells (Figure 5B). Also evident
is that basal OCR was inhibited by etomoxir
(Figure 5B, left), further demonstrating that
IL-15 memory T cells use FAO for energy in
a resting state. In contrast, OCR in IL-2 Teff cells
was not affected by etomoxir (Figure 5C).
Consistent with these findings, SRC in bonafide CD8+memory T cells isolated after L. monocytogenes infec-
tion was also impaired by etomoxir, whereas the OCR after
FCCP in CD8+ Teff cells was not affected (Figure 5D). To test
whether the inhibition of FAO alters the survival of IL-15 memory
T cells in vitro, we cultured cells with etomoxir and found that
CPT1a inhibition impaired their survival (Figure S4).
To further substantiate that SRC is regulated by FAO, we next
used a genetic approach. We modulated the expression of
CPT1a by transducing CD8+ T cells with retrovirus expressing
shRNA against CPT1a (hpCPT1a) and found that inhibiting
CPT1a expression in IL-15 memory T cells reduced maximum
OCR after injection of FCCP (Figure 6A), whereas hpCPT1a
expression did not affect maximum OCR in IL-2 Teff cells (Fig-
ure 6B). To assess the effect of a genetic gain of function for
FAO, we retrovirally expressed CPT1a (CPT1a EX) in CD8+
T cells. Retroviral expression of CPT1a significantly enhanced
maximal OCR after FCCP in both IL-15 memory T cells (Fig-
ure 6C) and IL-2 Teff cells (Figure 6D). The same results were
found when the data were expressed as SRC (Figures 6A–6D,
where maximum OCR after FCCP is calculated as a percentage
of baseline OCR). The efficacy of the hpCPT1a and CPT1a
EX to modulate the expression of CPT1a was confirmed
(Figure S5A). We further verified that CPT1a EX directly
promoted FAO by showing that etomoxir inhibits the enhanced
maximum OCR in CPT1a EX IL-15 memory T cells to a greater
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Figure 5. Spare Respiratory Capacity in
CD8+ T Cells Is Dependent on Mitochon-
drial FAO
(A) Relative CPT1a mRNA expression in IL-2
Teff and IL-15 memory T cells (figure generated
from data from five independent experiments);
*p = 0.003.
(B–D) Oxygen consumption rates (OCR) in IL-15
memory T cells (B), in IL-2 Teff and IL-15 memory
T cells (C), and bona fide Teff and memory T cells
isolated from LmOVA-infected B6 mice (D), under
basal conditions and in response to indicated
drugs; p < 0.0001 (after FCCP in B left panel),
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Consistent with increased SRC, retroviral CPT1a expression
enhanced the survival of IL-15 memory T cells in vitro (Fig-
ure S5C). Together these data establish that increased FAO
positively regulates SRC in CD8+ T cells and thereby favors
cellular survival.
Mitochondrial FAO Enhances T Cell Survival and
Promotes CD8+ Memory T Cell Development
To explore whether CPT1a, and thus FAO, supports Ag-specific
CD8+ T cell survival in vivo, we adoptively transferred activated
control-transduced or CPT1a EX-transduced OT-I T cells into
congenic mice and found significantly more CPT1a EX-trans-
duced donor cells in spleen and lymph nodes than control-
transduced donor cells after 2 days (Figure 7A), indicating that
CPT1a increases survival of Ag-specific CD8+ T cells in vivo.
Finally, to establish that FAO regulates development of CD8+
memory T cells, we adoptively transferred activated control-
transduced andCPT1a EX-transducedOT-I T cells into congenic
recipients and tracked OVA-specific CD8+ T cell responses after
immunization with L. monocytogenes. The frequency of OVA-
specific cells that are control transduced remains the sameImmunity 36, 68–7from the Teff cell phase to the memory
T cell phase (Figure 7B, compare 66%
for Teff to 68% for memory T cells, con-
tour plots and left bar graph), indicating
that there was no advantage to express-
ing the control vector in promoting cell
survival. However, the frequency of
CPT1a EX-transduced cells significantly
increased from the peak of the Teff cell
response through contraction (Figure 7B,
compare 58% for Teff to 87% for memory
T cells, contour plots and left bar graph).
The advantage to expressing the CPT1a
EX vector was demonstrated by less
contraction (Figure 7B, middle bar graph)
and resulted in higher absolute numbers
of CPT1a EX-transduced memory T cells
as compared to control-transduced
memory T cells, both in blood (Figure 7B,middle bar graph) and in spleen (Figure 7B, right bar graph).
Furthermore, total memory T cells increased in mice that
received adoptive transfers of CPT1a EX-transduced cells, sug-
gesting that the CPT1a pathway is a limiting factor in memory
T cell generation (Figures S6A and S6B). Together, these data
show that CPT1a, and thus FAO, promotes the development of
CD8+ memory T cells after infection.
To determine the extent to which the effects of IL-15 signals on
CD8+ memory T cells in vivo are CPT1a dependent, we adop-
tively transferred activated control-transduced and CPT1a
EX-transduced OT-I T cells into IL-15-deficient recipients and
tracked OVA-specific CD8+ T cell responses after immunization
with L. monocytogenes. Although the frequencies of control and
CPT1a EX-transduced cells were similar at the peak of the
response (Teff cells), more CPT1a EX-transduced cells survived
contraction and subsequently were able to respond to a chal-
lenge infection (Figure 7C). We found, however, that the survival
of both control and CPT1a EX-transduced cells was reduced in
IL-15-deficient recipients when compared to WT recipient mice
(Figure S6C). These results suggest that IL-15 signals promote
CPT1a expression and FAO to support CD8+ memory T cells,
but that this is not the only function of IL-15.8, January 27, 2012 ª2012 Elsevier Inc. 73
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Figure 6. Spare Respiratory Capacity in CD8+ T Cells Is Dependent
on CPT1a Expression
Maximum OCR (as indicated by OCR after injection of oligomycin and
subsequent FCCP) and spare respiratory capacity (indicated by maximum
OCR calculated as percentage of baseline OCR) in IL-15 memory T cells (A, C)
and IL-2 Teff cells (B, D) cells transduced with either control (virus expressing
shRNA against luciferase) or virus expressing shRNA against CPT1a
(hpCPT1a) (A, B), and either control (empty vector) or CPT1a expressing (EX)
retrovirus (C, D); *p = 0.03 (A), 0.003 (max OCR) and 0.02 (SRC) (C), 0.006 (max
OCR) and 0.03 (SRC) (D). Data are representative of at least two independent
experiments, and shown as mean ± SEM. See also Figure S5.
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We propose a model where mitochondrial respiratory capacity
regulates T cell survival after infection. As Teff cells undergo
clonal expansion during an immune response, they primarily
use glycolysis to support rapid cell growth. We speculate that
during this process, themajority of CD8+ Teff cells fail tomaintain
and/or induce mitochondrial biogenesis and this results in
a reduction in the ratio between mitochondrial mass and overall
cell mass and a consequential loss of reserve energy-generating
capacity, i.e., SRC. Reduced mitochondrial mass increases
dependence on glycolysis and renders Teff cells bioenergetically
unstable as they lose the ability to create energy from diverse
substrates via OXPHOS, and thus are unable to maintain viability
when infection-associated signals decline and elements such as
IL-2 that support glycolysis dissipate. Some Ag-specific T cells
from the primary infection survive as long-lived memory T cells
because they maintain mitochondrial mass via exposure to
IL-15 or perhaps other common g cytokines such as IL-7.
Because FAO occurs in mitochondria, more mitochondrial
mass allows greater use of fatty acids for energy via OXPHOS,
thereby facilitating cell survival in the absence of proglycolysis
signals. Moreover, the enhanced SRC provided by increased
mitochondrial mass might allow memory T cells to respond
quickly (‘‘rapid recall’’) if pathogen is reencountered.
Whether T cells receive growth factor signals can be controlled
at many levels, including cytokine and cytokine receptor ex-
pression, trans-presentation of the cytokine to the T cells by
antigen-presenting cells or other accessory cells (McGill et al.,
2010; Stonier et al., 2008), or T cell localization to niches where
a cytokine is expressed. It is likely that whether T cells are
able to receive signals from growth factors in vivo is a result of
a combination of these mechanisms. Our preliminary observa-
tions indicate that lymph node homing receptors are upregulated
immediately upon IL-2 withdrawal in vitro, suggesting that once
infection-associated signals such as IL-2 dissipate, cells
become competent to traffic to lymph nodes where they gain
access to IL-15 or IL-7. Additionally, it has been shown that
Ag-specific CD8+ cells that have not fully differentiated into
terminal Teff cells during primary infection express IL-7R and
persist as long-lived memory T cells (Kaech et al., 2003). This
suggests that these T cells have maintained mitochondrial
function throughout contraction because of continual signals
from IL-7.
The IL-2 and IL-15 receptors share identical subunits and
their signaling pathways overlap (Hofmann et al., 2002; Wald-
mann et al., 1998), implying that the strength of signal through
the cytokine receptor, rather than the mere induction of these
pathways, may lead to the differential effects of IL-2 compared
to IL-15 on Teff cells versus memory T cell differentiation (Carrio
et al., 2004; Cornish et al., 2006). However, our unpublished
observations suggest that overall Stat5 phosphorylation is
similar between our cultured IL-2 Teff and IL-15 memory
T cells, indicating that at least the degree of Stat5 activation
per se is not sufficient to dictate the differential effects of these
cytokines. More work needs to be done to determine whether
there is a unique signaling element, perhaps shared by IL-15
and IL-7 that supports memory T cell development (Carrio
et al., 2004).
Figure 7. Mitochondrial FAO Enhances T Cell Survival and Promotes CD8+ Memory T Cell Development
(A and B) OVA peptide-activated OT-I cells transduced with control (empty vector) or CPT1a expressing (EX) retrovirus were intravenously injected into congenic
recipients (n = 5 per group), and (A) organs were harvested 2 days later; dot plots show percentages (top) or total numbers (bottom) of donor cells (mean ± SEM);
*p < 0.0001 (top left), *p < 0.0001 (top right), 0.03 (bottom left), and 0.0006 (bottom right), or (B) mice were infected with LmOVA, and peripheral blood CD8+ T cells
were analyzed by KbOVA tetramer (line graphs) andGFP for retroviral expression (contour plots) at the peak of the response (Teff cells, day 7) and after contraction
(memory T cells, day 14). Contour plots and bar graphs show the frequency of transduced (GFP+) cells within the CD8+ and KbOVA tetramer-positive gate in blood
(left bar graph; *p = 0.0003), absolute numbers of transduced (GFP+) cells/ml blood (middle bar graph, data are normalized to control Teff cells; p = 0.02, numbers
above bars indicate fold contraction), and absolute numbers of transduced (GFP+) cell in spleen (right bar graph, data are normalized to control Teff cells). Data
are shown as mean ± SEM and are representative of at least two independent experiments with at least five mice per group.
(C) OT-I cells transduced with control (empty vector) or CPT1a expressing (EX) retrovirus were intravenously injected into IL-15-deficient recipients (n = 5 per
group) and mice were infected with LmOVA. Bar graphs show the frequency of transduced (GFP+) cells within the KbOVA tetramer gate at the peak of the
response (Teff cells, day 7), after contraction (memory T cells, day 14) and after challenge (recall, day 5 postchallenge); *p = 0.01. Data are shown as mean ± SEM
and are representative of two independent experiments. See also Figure S6.
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Mitochondrial Capacity and CD8+ T Cell MemoryOur data showing that retroviral expression of CPT1a facili-
tates CD8+ memory T cell development in IL-15-deficient mice,
but not to the same extent as in WT recipients, suggest that
although IL-15 does promote FAO to support memory T cells,
this is not the only function of IL-15 during an immune response.
We speculate that mitochondrial biogenesis is key to stable
memory T cell formation and that this is regulated by IL-15.
Although CPT1a EX-transduced cells increase FAO because of
enhanced CPT1a expression, they lack the mitochondrial
mass, and thus energy-producing machinery, to maintain full
bioenergetic stability when in an IL-15-deficient environment.
Although we believe that our findings show how metabolism
regulates T cell responses after infection, several questions
remain. For example, how do Teff cells come to have less SRC
than memory T cells? Although it has been described that
mitochondrial biogenesis is upregulated early after CD8+ T cell
activation (D’Souza et al., 2007), we speculate that Ag-specific
Teff cells that continue to proliferate during infection might
eventually outpace their own mitochondrial biogenesis, explain-
ing why Teff cells have less mitochondrial mass. It is also
possible that mitochondria segregate unequally as T cells asym-
metrically divide so that terminally differentiated Teff cells
acquire fewer mitochondria (Chang et al., 2007). Another unre-
solved issue is that of why Tn cells have less SRC than do
memory T cells? We have shown here that Tn cells have less
mitochondrial mass than memory T cells, which correlates with
their decreased SRC. It is also possible that qualitative differ-
ences exist between the mitochondria in Tn and memory
T cells, such as differences in expression of ETC complexes
on a per mitochondrion basis, which could in part be explained
by the effects of IL-15 on memory T cells after infection. This
suggests that cell-intrinsic bioenergetic differences underlie
the disparity in functionality between Tn and memory T cells,
i.e., the rapid recall of memory T cells is possible because of
enhanced SRC. All of these areas are actively under study.
Agents that protect cells against loss in mitochondrial SRC,
or that induce mitochondrial biogenesis, are thought to have
potential for treating numerous pathologies (Beeson et al.,
2010). Our findings here suggest that drugs that targetmitochon-
drial SRC could hold promise as immunotherapeutics and might
warrant further study for their ability to alter T cell responses.
These results may serve to focus scientific efforts toward inves-
tigating how mitochondria dictate T cell function and lifespan,
and thus impact how successful therapies and vaccines are
designed.
EXPERIMENTAL PROCEDURES
Mice and Immunizations
C57BL/6, C57BL/6 CD45.1, C57BL/6 CD90.1, and major histocompatibility
complex class I-restricted OVA-specific T cell receptor (OT-I) transgenic
mice were purchased from The Jackson Laboratory, and rederived stocks
were maintained at the Trudeau Institute under specific-pathogen-free condi-
tions under protocols approved by the Institutional Animal Care and Use
Committee. IL-15-deficient mice (Il15/) were purchased from Taconic. We
used the attenuated strain of recombinant Listeria monocytogenes deleted
for actA (LmOVA) for immunizations. Mice were infected intravenously or intra-
peritoneally with a sublethal dose of 1 3 107 to 5 3 107 colony-forming units
(CFU), and if indicated challenge infected with 5 3 107 CFU (Pearce et al.,
2009). Tn, Teff, and memory T cell isolations from spleens and lymph nodes
were done based on CD8, CD44, and CD62L expression (CD44loCD62Lhi,76 Immunity 36, 68–78, January 27, 2012 ª2012 Elsevier Inc.CD44hiCD62Llo, and CD44hiCD62Lhi, respectively) or donor marker at 6–
7 days (Teff cells) or 14–40 days (memory T cells) after infection, with the BD
Influx sorter or MACS purification (Miltenyi Biotech).
Flow Cytometry
All fluorochrome-conjugated monoclonal antibodies were purchased from
BD PharMingen or eBioscience. All staining was performed as previously
described (Pearce et al., 2009). OVA-specific CD8+ T cells were quantified
by direct staining with H2-Kb OVA257–264 (K
bOVA) MHC-peptide tetramers,
either by killing animals and collecting cells from organs or by collecting blood
from live animals (serial bleeds), as indicated. Mitochondrial membrane
potential was measured with 3,30-dihexyloxacarbocyanine iodide (DiOC6)
(Invitrogen) and superoxide production with dihydroethidium (HE) (Sigma).
In Vitro Cultures and Retroviral Transductions
OT-I splenocytes were activated with OVA-peptide and IL-2 (100 U/ml) for
3 days and subsequently cultured in the presence of either IL-2 or IL-15
(10 ng/ml) for 4 days. For restimulation assays, activated T cells were reacti-
vated with anti-CD3 (5.0 mg/ml) + anti-CD28 (0.5 mg/ml). For retroviral
transduction experiments, OT-I splenocytes were activated, transduced
with control (empty vector or virus expressing shRNA against luciferase),
CPT1a-expressing virus (CPT1a EX), or virus expressing shRNA against
CPT1a (hpCPT1a) 1 day later and subsequently cultured as described. GFP
is a marker of retroviral expression. For in vitro survival assays, OT-I spleno-
cytes were activated for 3 days as described, then plated (1 3 105 cells) in
a 96-well plate in the presence of the indicated cytokine and (if indicated)
200 mM etomoxir and daily analyzed for 7-AAD staining.
Adoptive Transfers
For adoptive transfer experiments, naive OT-I cells were obtained from the
blood or spleen, KbOVA tetramers were used to determine numbers of OT-I
cells, and then 1–3 3 104 OT-I cells were transferred into CD45.1 or CD90.1
congenic recipient mice. For in vivo survival analysis of cultured IL-2 Teff
and IL-15 memory T cells, 1 3 106 cells were transferred into congenic recip-
ient mice. For adoptive transfer of retrovirally transduced OT-I cells for in vivo
survival analysis, GFP+ cells were sorted and 1 3 106 cells were transferred
into CD45.1 congenic recipient mice. For adoptive transfer of retrovirally
transduced OT-I cells for memory T cell development, 1 3 105 GFP+ cells
were transferred into CD45.1 congenic or IL-15-deficient recipient mice.
Metabolism Assays
Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR)
were measured in XF media (nonbuffered RPMI 1640 containing 25 mM
glucose, 2 mM L-glutamine, and 1 mM sodium pyruvate) under basal condi-
tions and in response to 200 mM etomoxir, 1 mM oligomycin, 1.5 mM fluoro-
carbonyl cyanide phenylhydrazone (FCCP), and 100 nM rotenone + 1 mM
antimycin A (Sigma), or PMA (50 ng/ml) + ionomycin (500 ng/ml) with the
XF-24 Extracellular Flux Analyzer (Seahorse Bioscience). NAD(H) measure-
ments were performed with the NAD+ and NADH Quantification Kit (BioVision)
and ATP measurements with the ATP determination kit (Invitrogen).
Imaging
IL-2 Teff cells and IL-15 memory T cells were stained for CD8 (BD Bioscience),
Mitotracker green, and Hoechst (Invitrogen). Tn, Teff, andmemory T cells were
sorted by CD44, CD8, and CD62L after L. monocytogenes infection and
stained with Mitotracker green and Hoechst.
RT-PCR and Immunoblot Analysis
RNA isolations were done with the RNeasy kit (QIAGEN) and single-strand
cDNA was synthesized with High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). Genomic DNA was extracted with the phenol-chloro-
form method to determine mtDNA/nDNA ratios (Guo et al., 2009). Primers
were purchased from Applied Biosystems and real-time PCR was performed
by the Taqman method with an Applied Biosystems 7500 sequence detection
system. The expression of mRNA for genes of interest was normalized to
the expression of a housekeeping gene (GAPDH). Cell lysate preparation,
SDS-PAGE, electrophoretic transfer, immunoblotting, and development via
enhanced chemiluminescence were accomplished as previously described
Immunity
Mitochondrial Capacity and CD8+ T Cell Memory(Pearce et al., 2009). The Complex I antibody (subunit NDUFB8) for immunoa-
nalysis was purchased from Mitosciences.
Statistical Analysis
Comparisons for two groups were calculated by unpaired two-tailed Student’s
t tests and comparisons for more than two groups were calculated by 1-way
ANOVA followed by Bonferroni’s multiple comparison tests. Comparisons
over time were calculated by 2-way ANOVA followed by Bonferroni’s multiple
comparison tests.
SUPPLEMENTAL INFORMATION
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